Neoadjuvant Chemoradiotherapy With S-1 in Patients With Borderline Resectable Pancreatic Cancer with Involvement of the Major Artery

被引：0
|
作者：
Suenaga, M. [1 ]
Fujii, T. [1 ]
Yamada, S. [1 ]
Okumura, N. [1 ]
Kobayashi, D. [1 ]
Tanaka, C. [1 ]
Nakayama, G. [1 ]
Sugimoto, H. [1 ]
Koike, M. [1 ]
Nomoto, S. [1 ]
Fujiwara, M. [1 ]
Takeda, S. [1 ]
Nakao, A. [2 ]
Kodera, Y. [1 ]
机构：
[1] Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Nagoya, Aichi 4648601, Japan
[2] Nagoya Cent Hosp, Dept Surg, Nagoya, Aichi, Japan
来源：
PANCREAS | 2012年 / 41卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1405 / 1405
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant chemoradiotherapy with S-1 in patients with borderline resectable pancreatic cancer
    Hattori, Masashi
    Fujii, Tsutomu
    Suenaga, Masaya
    Yamada, Suguru
    Kanda, Mitsuro
    Iwata, Naoki
    Kobayashi, Daisuke
    Tanaka, Chie
    Nakayama, Goro
    Sugimoto, Hiroyuki
    Koike, Masahiko
    Nomoto, Shuji
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [2] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Attaallah, Wafi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 3346 - +
  • [3] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Hayakawa, S.
    Karasawa, K.
    Fujisawa, T.
    Ito, K.
    Shibata, Y.
    Shimizuguchi, T.
    Nihei, K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E236 - E236
  • [4] Effect of neoadjuvant chemoradiotherapy on prognosis in resectable and borderline resectable pancreatic cancer with venous involvement.
    Nagai, Minako
    Sho, Masayuki
    Akahori, Takahiro
    Nakagawa, Kenji
    Nakamura, Kota
    Takagi, Tadataka
    Tanaka, Toshihiro
    Nishiofuku, Hideyuki
    Kichikawa, Kimihiko
    Ikeda, Naoya
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [5] Efficacy of Neoadjuvant Chemotherapy Using Gemcitabine and S-1 for Resectable and Borderline Resectable Pancreatic Cancer
    Aoki, T.
    Mori, S.
    Sakuraoka, Y.
    Suzuki, T.
    Nishi, Y.
    Arakawa, T.
    Shimizu, T.
    Tago, K.
    Park, K. H.
    Harada, N.
    Shiraki, T.
    Iso, Y.
    Kubota, K.
    [J]. PANCREAS, 2019, 48 (10) : 1404 - 1404
  • [6] Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
    di Sebastiano, Pierluigi
    Grottola, Tommaso
    di Mola, F. Francesco
    [J]. UPDATES IN SURGERY, 2016, 68 (03) : 235 - 239
  • [7] Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
    Pierluigi di Sebastiano
    Tommaso Grottola
    F. Francesco di Mola
    [J]. Updates in Surgery, 2016, 68 : 235 - 239
  • [8] Neoadjuvant Phase II Trial of Chemoradiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer
    Thanikachalam, Kannan
    Damarla, Vijay
    Seixas, Trevor
    Dobrosotskaya, Irina
    Wollner, Ira
    Kwon, David
    Winters, Kenneth
    Raoufi, Mohammad
    Li, Jia
    Siddiqui, Farzan
    Khan, Gazala
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (06): : 435 - 441
  • [9] Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
    Versteijne, Eva
    de Hingh, Ignace H. J. T.
    Homs, Marjolein Y. V.
    Intven, Martijn P. W.
    Klaase, Joost M.
    van Santvoort, Hjalmar C.
    de Vos-Geelen, Judith
    Wilmink, Johanna W.
    van Tienhoven, Geertjan
    [J]. FRONTIERS IN ONCOLOGY, 2022, 11
  • [10] Local Immunological Effect of Neoadjuvant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Cancer
    Murakami, T.
    Mori, R.
    Matsuyama, R.
    Homma, Y.
    Nakazawa, M.
    Tanaka, Y.
    Miyake, K.
    Sawada, Y.
    Oota, Y.
    Hiroshima, Y.
    Kumamoto, T.
    Ueda, M.
    Takeda, K.
    Ichikawa, Y.
    Tanaka, K.
    Endo, I.
    [J]. PANCREAS, 2014, 43 (08) : 1394 - 1394
12345